Aurinia director granted 23,931 stock options
Aurinia Pharmaceuticals Inc. director Jeffrey Allen Bailey received a grant of stock options as part of his compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aurinia Pharmaceuticals Inc. director Jeffrey Allen Bailey received a grant of stock options as part of his compensation. The award covers 23,931 options to purchase common shares at an exercise price of $15.67 per share. These options vest one year from the grant date and expire on June 4, 2036. Following this grant, Bailey holds 23,931 options directly, with no open-market purchases or sales reported in this filing.
Insider Trade Summary
Grant/Award: 23,931 shares
Grant/Award
1 txn
Insider
Bailey Jeffrey Allen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 23,931 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Option (right to buy) — 23,931 contracts (Direct)
Footnotes (1)
- F1. The options shall vest one year from date of grant.
Key Figures
Options granted: 23,931 options
Exercise price: $15.67 per share
Underlying shares: 23,931 common shares
+2 more
5 metrics
Options granted
23,931 options
Director stock option grant on June 4, 2026
Exercise price
$15.67 per share
Exercise price for granted options
Underlying shares
23,931 common shares
Shares underlying the stock options
Post-grant option holdings
23,931 options
Total options held following transaction
Option expiration date
June 4, 2036
Expiration of director stock options
Key Terms
Director Stock Option (right to buy), exercise price, expiration date, underlying security, +1 more
5 terms
Director Stock Option (right to buy) financial
"security_title: "Director Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "15.6700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Shares""
vest financial
"The options shall vest one year from date of grant."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Aurinia Pharmaceuticals (AUPH) director Jeffrey Allen Bailey report in this Form 4?
Director Jeffrey Allen Bailey reported receiving a grant of stock options. The award covers 23,931 options to buy Aurinia common shares at $15.67 per share, reflecting compensation rather than an open-market stock purchase or sale.
How many Aurinia Pharmaceuticals (AUPH) options were granted to director Jeffrey Allen Bailey?
Jeffrey Allen Bailey was granted 23,931 stock options. Each option represents the right to purchase one Aurinia common share, giving him potential future ownership if he chooses to exercise the options at the stated exercise price.
What is the exercise price of Jeffrey Allen Bailey’s Aurinia (AUPH) stock options?
The exercise price of Bailey’s options is $15.67 per share. This is the fixed price at which he can buy Aurinia common shares through these options, regardless of the market price at the time of exercise.
When do Jeffrey Allen Bailey’s Aurinia Pharmaceuticals (AUPH) options vest and expire?
The options vest one year from the grant date and expire on June 4, 2036. Vesting after one year means Bailey must remain eligible through that period before he can exercise the stock options.
Does this Aurinia (AUPH) Form 4 show any stock being bought or sold on the market?
No, the Form 4 shows a compensation-related option grant, not market trades. Bailey received 23,931 options with no open-market purchases or sales of Aurinia common shares reported in this particular filing.
How many Aurinia (AUPH) options does Jeffrey Allen Bailey hold after this transaction?
After the reported grant, Bailey holds 23,931 stock options directly. This total equals the number of options granted in the transaction, indicating this Form 4 reflects a new award rather than changes to an existing option position.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates